Driving safety with numb feet from peripheral neuropathy: how to know when your feet are lying to you

A close-up photo capturing a bare foot casting a dramatic shadow on the ground.

Numb feet change driving because the pedal feedback loop depends on sensation you may no longer have. The National Institute of Neurological Disorders and Stroke lists inability to feel vibration and touch, especially in the hands or feet, and loss of position sense among the symptoms of sensory nerve involvement.1 Both of those are exactly what you use to find a pedal and judge how hard you are pressing it.

Why sensation, not pain, is the driving question

Driving is a correction loop. You press, you feel the resistance, you adjust. When touch and position sense are degraded, the correction arrives late or lands in the wrong place.

NINDS also notes that loss of position sense can leave a person unable to coordinate complex movements or maintain balance with their eyes shut.1 A footwell is a dark place where your eyes cannot help you.

Symptoms can arrive on any timescale

NINDS states that symptoms of peripheral neuropathy may develop over days, weeks or years, depending on the type of nerve fibers affected and the type and severity of damage.1 That is why a driving judgment made two years ago is not a judgment about today.

Reassess after any medication change, any fall, any new numbness, and after any near-miss you explained away. You can read how the sensory pattern is described clinically in peripheral neuropathy of the feet symptoms.

What the driving research shows

Brake response time

A 2017 case-control study in the Journal of Foot and Ankle Surgery measured brake response time on a computerized driving simulator in 25 active drivers with type 2 diabetes and lower extremity neuropathy against 25 active drivers with neither condition.2 The neuropathy group had a slower mean brake response time, and abnormally delayed responses occurred more often.

Pressing the wrong pedal

A 2026 study in Transportation Research Interdisciplinary Perspectives compared drivers with and without neuropathy affecting foot sensation and ankle proprioception in a driving simulation.3 Only the drivers with neuropathy produced sudden, powerful, unsafe and unintended accelerations when braking was needed — instances of pedal confusion and misapplication.

The authors state that diabetic peripheral neuropathy increases the likelihood of pressing the wrong pedal, which places those drivers at increased risk of crash from unintended acceleration.3 They recommend three countermeasures: driving a manual gearbox rather than an automatic, fitting an acceleration limiter, and lighting the footwell and pedals at night.

Patient reclined for small-fiber and autonomic nerve testing, with sensor cuffs on both ankles and wrists, at Regenerve, 4477 Woodson Rd, St. Louis, MO 63134

Signs it is time to stop and get evaluated

These are the patterns worth acting on rather than absorbing:

  • Numbness that is spreading or deepening over weeks rather than staying stable.
  • Having to hunt for the pedal, or being unsure how far down you have pushed it.
  • Any episode of unintended acceleration, pedal confusion, or a near-miss you cannot explain.
  • New unsteadiness on uneven ground or in the dark.
  • A new medication that affects alertness, balance or reaction time.

If driving already feels unreliable, pause it while you get evaluated rather than testing the question on a public road.

What an evaluation at Regenerve looks at

The useful question is not whether you have neuropathy but which driver is causing it and which specific functions have been lost. We perform electrodiagnostic testing (EMG/NCS) on site, and we sort between metabolic, nutritional, autoimmune, toxic and structural drivers.

Where balance is part of the picture, we use VNG as a diagnostic test of inner-ear balance function. VNG is a test, not a treatment. Our therapy options include class 4 photobiomodulation, class 3B cold laser and whole-body infrared.

Orthobiologic injections such as PRP and BMAC are offered in selected situations. Qutenza (capsaicin 8% patch) is FDA-approved in adults only for neuropathic pain from postherpetic neuralgia and from diabetic peripheral neuropathy of the feet; any other use is off-label. It is applied in clinic by a clinician and repeated no more often than every three months. We do not promise nerve regeneration, reversal or cure.

We see patients from the St. Louis region, Missouri and Illinois, at 4477 Woodson Rd #104, St. Louis, MO 63134. Details are on our St. Louis neuropathy treatment page.

Start with your Nerve Damage Score

If your feet have gone quiet, find out what is causing it before you decide anything about driving. The Nerve Damage Score is a free five-question screen.

Frequently asked questions

Can I keep driving if my feet are numb from neuropathy?

That depends on how much sensation and position sense you have lost, and it is not something to judge from a good day. NINDS lists inability to feel vibration and touch and loss of position sense among sensory nerve symptoms, and both affect how accurately you place and load a pedal. See burning feet and nerve pain.

What is pedal confusion, and is neuropathy really linked to it?

Pedal confusion means pressing the accelerator when you intended to brake. In a 2026 driving-simulation study, only drivers with diabetic peripheral neuropathy produced sudden, powerful, unsafe and unintended accelerations when braking was needed. See the hidden drivers of peripheral neuropathy.

What should I ask about before a driving decision?

Ask about your sensory examination, your position sense, your medications, and whether a formal driver rehabilitation evaluation is appropriate for you. Bring the specific driving moments that feel unreliable rather than a general impression. See Regenerve services and testing.

Does treating the pain make driving safer?

Not by itself. Pain relief and sensory accuracy are different things, and a treatment that reduces burning does not restore the pressure and position feedback a pedal needs. Qutenza, for example, is approved for neuropathic pain, not for sensory recovery. See Qutenza (capsaicin 8% patch).

Sources

  1. National Institute of Neurological Disorders and Stroke. “Peripheral Neuropathy.” Last reviewed March 13, 2026. https://www.ninds.nih.gov/health-information/disorders/peripheral-neuropathy
  2. Meyr AJ, Spiess KE. “Diabetic Driving Studies—Part 1: Brake Response Time in Diabetic Drivers With Lower Extremity Neuropathy.” Journal of Foot and Ankle Surgery. 2017;56(3):568–572. https://pubmed.ncbi.nlm.nih.gov/28476387/
  3. Perazzolo M, Esselaar M, Marple-Horvat DE. “Sudden, powerful, unsafe and unintended accelerations: Pedal confusion and misapplication in drivers with diabetic peripheral neuropathy.” Transportation Research Interdisciplinary Perspectives. 2026;38:102129. https://doi.org/10.1016/j.trip.2026.102129